M.E. Witt

1.1k total citations
26 papers, 795 citations indexed

About

M.E. Witt is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, M.E. Witt has authored 26 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Otorhinolaryngology, 12 papers in Oncology and 11 papers in Surgery. Recurrent topics in M.E. Witt's work include Head and Neck Cancer Studies (17 papers), Head and Neck Surgical Oncology (10 papers) and Cancer Diagnosis and Treatment (7 papers). M.E. Witt is often cited by papers focused on Head and Neck Cancer Studies (17 papers), Head and Neck Surgical Oncology (10 papers) and Cancer Diagnosis and Treatment (7 papers). M.E. Witt collaborates with scholars based in United States, Germany and Argentina. M.E. Witt's co-authors include Everett E. Vokes, Daniel J. Haraf, Bharat B. Mittal, Kerstin Stenson, Ralph R. Weichselbaum, M.S. Kies, F. Rosen, Ralph Weichselbaum, Bruce Brockstein and Ezra E.W. Cohen and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

M.E. Witt

26 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.E. Witt United States 13 532 441 286 207 101 26 795
Rosalie Ho Hong Kong 4 884 1.7× 555 1.3× 439 1.5× 413 2.0× 29 0.3× 8 1.1k
Chen‐Yi Hsu Taiwan 13 836 1.6× 596 1.4× 373 1.3× 204 1.0× 10 0.1× 28 1.0k
Christopher S. Lauer Australia 11 181 0.3× 231 0.5× 368 1.3× 46 0.2× 31 0.3× 20 629
Navin Mani United Kingdom 10 226 0.4× 117 0.3× 140 0.5× 129 0.6× 10 0.1× 18 533
Ramya P. Masand United States 12 135 0.3× 192 0.4× 103 0.4× 99 0.5× 35 0.3× 37 664
Azfar Neyaz United States 13 109 0.2× 239 0.5× 298 1.0× 117 0.6× 16 0.2× 39 614
Christine Loo Australia 12 53 0.1× 120 0.3× 94 0.3× 81 0.4× 69 0.7× 36 482
Kanjana Shotelersuk Thailand 10 113 0.2× 136 0.3× 174 0.6× 86 0.4× 14 0.1× 32 520
M Cammoun Tunisia 15 110 0.2× 123 0.3× 319 1.1× 61 0.3× 22 0.2× 31 565
Medhat El-Sebaie Saudi Arabia 11 103 0.2× 146 0.3× 105 0.4× 89 0.4× 15 0.1× 19 387

Countries citing papers authored by M.E. Witt

Since Specialization
Citations

This map shows the geographic impact of M.E. Witt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.E. Witt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.E. Witt more than expected).

Fields of papers citing papers by M.E. Witt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.E. Witt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.E. Witt. The network helps show where M.E. Witt may publish in the future.

Co-authorship network of co-authors of M.E. Witt

This figure shows the co-authorship network connecting the top 25 collaborators of M.E. Witt. A scholar is included among the top collaborators of M.E. Witt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.E. Witt. M.E. Witt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Danker, Kerstin, et al.. (2024). Upregulation of psoriasin/S100A7 correlates with clinical severity in patients with oral lichen planus. Clinical Oral Investigations. 28(6). 318–318. 2 indexed citations
3.
Staufenbiel, Sven, et al.. (2024). Topical Application of Dexamethasone‐Loaded Core‐Multishell Nanocarriers Against Oral Mucosal Inflammation.. Macromolecular Bioscience. 24(12). e2400286–e2400286. 2 indexed citations
4.
Karrison, Theodore, M.E. Witt, Charles Muller, et al.. (2014). Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades. Annals of Oncology. 26(1). 198–205. 9 indexed citations
5.
Seiwert, Tanguy Y., Thomas E. Darga, Daniel J. Haraf, et al.. (2012). A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Annals of Oncology. 24(3). 769–776. 23 indexed citations
6.
Golden, Daniel W., Sonali Rudra, M.E. Witt, et al.. (2012). Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma. Oral Oncology. 49(3). 277–282. 12 indexed citations
7.
Villaflor, Victoria, Daniel J. Haraf, Joseph K. Salama, et al.. (2011). Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck. Annals of Oncology. 22(11). 2501–2507. 16 indexed citations
8.
9.
Salama, Joseph K., Kerstin Stenson, Ezra E.W. Cohen, et al.. (2008). Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma. Annals of Oncology. 19(9). 1650–1654. 34 indexed citations
10.
Salama, Joseph K., K. M. Stenson, Emily O. Kistner, et al.. (2008). Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels. Annals of Oncology. 19(10). 1787–1794. 54 indexed citations
11.
Salama, Joseph K., Kerstin Stenson, Ezra E.W. Cohen, et al.. (2006). 24. International Journal of Radiation Oncology*Biology*Physics. 66(3). S14–S14. 5 indexed citations
12.
Brockstein, Bruce, Daniel J. Haraf, Alfred Rademaker, et al.. (2004). Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Annals of Oncology. 15(8). 1179–1186. 265 indexed citations
13.
Gustin, David M., Daniel J. Haraf, Kerstin Stenson, et al.. (2004). Treatment of advanced head and neck cancer with induction chemotherapy followed by chemoradiotherapy with reduced radiation dose. Journal of Clinical Oncology. 22(14_suppl). 5546–5546. 2 indexed citations
14.
Gustin, David M., D. Haraf, F. Rosen, et al.. (2004). Treatment of advanced head and neck cancer with induction chemotherapy followed by chemoradiotherapy with reduced radiation dose. Journal of Clinical Oncology. 22(14_suppl). 5546–5546. 2 indexed citations
15.
Oh, Julia, Everett E. Vokes, M.S. Kies, et al.. (2003). Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Annals of Oncology. 14(4). 564–569. 71 indexed citations
16.
Mantz, C.A., Everett E. Vokes, M.S. Kies, et al.. (2001). Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Annals of Oncology. 12(3). 343–347. 25 indexed citations
17.
18.
Vokes, Everett E., et al.. (1999). Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results.. PubMed. 5(4). 219–23. 46 indexed citations
19.
Bramel‐Cox, P. J., et al.. (1990). Potential Gain from Selection in Grain Sorghum for Higher Protein Digestibility. Crop Science. 30(3). 521–524. 7 indexed citations
20.
Ginsberg‐Fellner, Fredda, M.E. Witt, Soroku Yagihashi, et al.. (1984). Congenital rubella syndrome as a model for Type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia. 27(S1). 87–89. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalie Ho Breakdown of academic impact, for papers by Chen‐Yi Hsu Breakdown of academic impact, for papers by Christopher S. Lauer Breakdown of academic impact, for papers by Navin Mani Breakdown of academic impact, for papers by Ramya P. Masand Breakdown of academic impact, for papers by Azfar Neyaz Breakdown of academic impact, for papers by Christine Loo Breakdown of academic impact, for papers by Kanjana Shotelersuk Breakdown of academic impact, for papers by M Cammoun Breakdown of academic impact, for papers by Medhat El-Sebaie
Rankless by CCL
2026